Nantahala Capital Management LLC Purchases New Stake in Viemed Healthcare, Inc. $VMD

Nantahala Capital Management LLC acquired a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 632,445 shares of the company’s stock, valued at approximately $7,209,873.

Other large investors have also added to or reduced their stakes in the company. AQR Capital Management LLC bought a new stake in Viemed Healthcare in the first quarter worth about $90,000. Jane Street Group LLC bought a new position in shares of Viemed Healthcare during the 1st quarter valued at approximately $394,000. Geode Capital Management LLC grew its position in shares of Viemed Healthcare by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 798,515 shares of the company’s stock valued at $5,519,000 after acquiring an additional 15,353 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Viemed Healthcare by 3.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 174,551 shares of the company’s stock worth $1,206,000 after purchasing an additional 5,099 shares during the last quarter. Finally, Rhumbline Advisers increased its stake in shares of Viemed Healthcare by 9.0% during the 2nd quarter. Rhumbline Advisers now owns 51,456 shares of the company’s stock worth $356,000 after purchasing an additional 4,228 shares during the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Price Performance

Shares of NASDAQ:VMD opened at $8.82 on Friday. The firm has a market capitalization of $335.95 million, a PE ratio of 24.50, a P/E/G ratio of 2.22 and a beta of 1.10. The company has a quick ratio of 1.02, a current ratio of 1.13 and a debt-to-equity ratio of 0.04. The company has a 50-day moving average price of $10.83 and a two-hundred day moving average price of $9.89. Viemed Healthcare, Inc. has a twelve month low of $6.05 and a twelve month high of $12.61.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings results on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.05). Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. The business had revenue of $78.10 million during the quarter, compared to the consensus estimate of $78.00 million. Equities analysts forecast that Viemed Healthcare, Inc. will post 0.41 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently commented on VMD shares. Freedom Capital downgraded Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Weiss Ratings downgraded Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, August 17th. Barrington Research initiated coverage on Viemed Healthcare in a research note on Monday, August 24th. They issued an “outperform” rating and a $14.00 target price on the stock. Finally, Wall Street Zen cut Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. One investment analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $14.00.

Insiders Place Their Bets

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total value of $230,000.00. Following the sale, the director owned 75,518 shares of the company’s stock, valued at $868,457. This trade represents a 20.94% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider William Frazier sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the sale, the insider directly owned 73,214 shares in the company, valued at $858,068.08. This represents a 12.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 20.60% of the stock is owned by insiders.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.